Journal
/
Pesquisa do Câncer
/
Establishing a Competing Risk Regression Nomogram Model for Survival Data
JoVE Journal
Pesquisa do Câncer
É necessária uma assinatura da JoVE para visualizar este conteúdo.  Faça login ou comece sua avaliação gratuita.
JoVE Journal Pesquisa do Câncer
Establishing a Competing Risk Regression Nomogram Model for Survival Data

Establishing a Competing Risk Regression Nomogram Model for Survival Data

DOI:
10.3791/60684-v

•

04:57 min

•

October 23, 2020

•

, , , , ,
1Department of Gastroenterology,Second Affiliated Hospital of Zhejiang University School of Medicine, 2Institute of Gastroenterology,Zhejiang University, 3Department of Colorectal Surgery, Afiliated Jinhua Hospital,Zhejiang University School of Medicine, 4Department of Medical Oncology, Affiliated Jinhua Hospital,Zhejiang University School of Medicine, 5Department of Hepatobiliary Pancreatic Surgery, Affiliated Jinhua Hospital,Zhejiang University School of Medicine, 6Division of Oncology,Johns Hopkins University School of Medicine

Capítulos

  • 00:04Introduction
  • 00:42Nomogram Based on the Cox Proportional Hazards Regression Model
  • 01:13Subgroup Analysis Based on the Group Risk Score
  • 01:43Nomogram Based on the Competing Risk Regression Model
  • 02:39Results: Competing-risk Nomogram and Risk Score Estimation
  • 04:10Conclusion

Summary

Tadução automática

Tadução automática

Presented here is a protocol to build nomograms based on the Cox proportional hazards regression model and competing risk regression model. The competing method is a more rational method to apply when competing events are present in the survival analysis.

Tags

Competing Risk RegressionSurvival AnalysisNomogramCox Proportional Hazards RegressionForest PlotCumulative Incidence FunctionKaplan-Meier Method

Article

Embed

ADICIONAR À PLAYLIST

Usage Statistics

Vídeos Relacionados

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Morphology-Based Distinction Between Healthy and Pathological Cells Utilizing Fourier Transforms and Self-Organizing Maps

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

A 3D Spheroid Model for Glioblastoma

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients

Nuclei Isolation from Fresh Frozen Brain Tumors for Single-Nucleus RNA-seq and ATAC-seq

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

An R-Based Landscape Validation of a Competing Risk Model

Read Article